Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2100071	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-11-18	view
JYSB2100070	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-11-18	view
JYSB1700108	Nivolumab注射液	nivolumab	Injection	Biological Products	Supplementary Application	2017-05-27	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	Certificate Issued	2017-10-09	view
JYSB1700107	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Supplementary Application	2017-05-27	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	Certificate Issued	2017-09-26	view
JYSB1600266	Nivolumab注射液	nivolumab	Injection	Biological Products	Supplementary Application	2016-12-14	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	Certificate Issued	2017-02-14	view
JYHZ2100008	卡铂注射液	carboplatin	Injection	Chemical Drugs	License Renew	2021-01-20	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Corden Pharma Latina SpA;Bristol-Myers Squibb SA	Certificate Issued	2021-07-20	view
JYHZ0900173	注射用盐酸头孢吡肟	cefepime hydrochloride	Lyophilized	Chemical Drugs	License Renew	2009-05-27	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Srl	Certificate Issued	2012-09-21	view
JYHZ0900172	注射用盐酸头孢吡肟	cefepime hydrochloride	Lyophilized	Chemical Drugs	License Renew	2009-06-01	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Srl	Certificate Issued	2012-09-21	view
JYHF1700045	阿舒瑞韦软胶囊	asunaprevir	Soft capsules	Chemical Drugs	Supplementary Application	2017-05-15	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Catalent Pharma Solutions LLC;Bristol-Myers Squibb (Singapore) Pte Ltd	Certificate Issued	2017-07-04	view
JYHF1700043	盐酸达拉他韦片	daclatasvir dihydrochloride	Tablet	Chemical Drugs	Supplementary Application	2017-05-15	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb (Singapore) Pte Ltd;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2017-07-04	view
JYHB1901305	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2019-11-02	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Certificate Issued	2020-01-06	view
JYHB1901304	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2019-11-09	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Certificate Issued	2020-01-06	view
JYHB1901182	BMS-986165	deucravacitinib	Active ingredient	Chemical Drugs	Supplementary Application	2019-10-15	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company	In Review	2019-10-14	view
JYHB1900824	盐酸达拉他韦片	daclatasvir dihydrochloride	Tablet	Chemical Drugs	Supplementary Application	2019-07-03	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb (Singapore) Pte Ltd;Astrazeneca Pharmaceuticals Lp	Filed	2019-07-12	view
JYHB1900767	阿舒瑞韦软胶囊	asunaprevir	Soft capsules	Chemical Drugs	Supplementary Application	2019-06-18	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Catalent Pharma Solutions LLC;Bristol-Myers Squibb (Singapore) Pte Ltd	Filed	2019-06-24	view
JYHB1801432	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2018-12-05	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Certificate Issued	2019-01-22	view
JYHB1801431	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2018-12-17	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Certificate Issued	2019-01-22	view
JYHB1800853	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2018-07-17	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Filed	2018-07-26	view
JYHB1800852	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2018-07-17	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Filed	2018-07-26	view
JYHB1800529	盐酸达拉他韦片	daclatasvir dihydrochloride	Tablet	Chemical Drugs	Supplementary Application	2018-05-08	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb (Singapore) Pte Ltd;Astrazeneca Pharmaceuticals Lp	Certificate Issued	2018-07-16	view